mapping the countermeasures world

https://www.bitchute.com/video/fzXuyIpZA58m/from early in 2020 during Trump admin. DoD signed contracts buying the supposed “vaccines”/gene manipulation/bioweapons from big pharma; DoD then owns them and distributes them including from Ft. Dietrick with no barcode or chain of custody (because US gov. agencies can hide their programs from everyone via a loophole, no paper trail shown or wanted—its “countermeasures”). It is DoD that stepped between FDA and pharma as the absoute middleman and DoD permits no other communication between big pharma and FDA but only through themselves. DoD hires untrained workers as another step of stealth, our DoD. DoD has signed many many contracts, not so much with Pfizer/Moderna/Fosun/ BioNTech but with many start-up pharma for many many more potential bioweapons. Now in early 2020 Kissinger was still for 1 more year on the Defense Policy Board that oversees DoD. Klaus Schwab studied under Kissinger a long time ago and likes him greatly. Evidence for these statements: 1) https://www.bitchute.com/video/fzXuyIpZA58m/ 2) start at 19: with Sasha Latypova at https://rumble.com/embed/v1xymve?pub=75zn/?autoplay=false; Sasha Latypova’ s main point is that this area of nano+ genetic engineering is far closer to destruction than useful medicine, and through decades of messing around with this a conclusion was likely reached that it was DoD territory. However, what about the rest of us? Meanwhile, what’s the deal with the lipid nanoparticle hydrogels and their contents? I think it’s partly Fosun, maybe partly BioNtech, more probably SinoPeg involvement, or in other words a two0party mutual off-shoring. Remember that offshore Hong Kong was the opium cartel base by the 1830s for getting into mainland China. Pegylated refers to lipid nanoparticle tech. PEGylation (or pegylation) is the process of both covalent and non-covalent attachment or amalgamation of polyethylene glycol (PEG, in pharmacy called macrogol) polymer chains to molecules and macrostructures, such as a drug, therapeutic protein or vesicle, which is then described as PEGylated.[1][2][3][4] PEGylation affects the resulting derivatives or aggregates interactions, which typically slows down their coalescence and degradation as well as elimination in vivo.[5][6] PEGylation is routinely achieved by the incubation of a reactive derivative of PEG with the target molecule. The covalent attachment of PEG to a drug or therapeutic protein can "mask" the agent from the host's immune system (reducing immunogenicity and antigenicity), and increase its hydrodynamic size (size in solution), which prolongs its circulatory time by reducing renal clearance. PEGylation can also provide water solubility to hydrophobic drugs and proteins. Having proven its pharmacological advantages and acceptability, PEGylation technology is the foundation of a growing multibillion-dollar industry.[7] ‘https://en.wikipedia.org/wiki/PEGylation ……………………. Weaponizing Biotech: How China's Military Is Preparing for a 'New Domain of Warfare' Under Beijing's civil-military fusion strategy, the PLA is sponsoring research on gene editing, human performance enhancement and more. Elsa B. Kania and Wilson VornDick | August 14, 2019 We may be on the verge of a brave new world indeed. Today’s advances in biotechnology and genetic engineering have exciting applications in medicine — yet also alarming implications, including for military affairs. China’s national strategy of military-civil fusion (军民融合) has highlighted biology as a priority, and the People’s Liberation Army could be at the forefront of expanding and exploiting this knowledge.   The PLA’s keen interest is reflected in strategic writings and research that argue that advances in biology are contributing to changing the form or character (形态) of conflict. For example: In 2010’s War for Biological Dominance (制生权战争), Guo Jiwei (郭继卫), a professor with the Third Military Medical University, emphasizes the impact of biology on future warfare.   In 2015, then-president of the Academy of Military Medical Sciences He Fuchu (贺福初) argued that biotechnology will become the new “strategic commanding heights” of national defense, from biomaterials to "brain control" weapons. Maj. Gen. He has since become the vice president of the Academy of Military Sciences, which leads China’s military science enterprise.  Biology is among seven "new domains of warfare" discussed in a 2017 book by Zhang Shibo (张仕波), a retired general and former president of the National Defense University, who concludes: “Modern biotechnology development is gradually showing strong signs characteristic of an offensive capability,” including the possibility that “specific ethnic genetic attacks” (特定种族基因攻击) could be employed.  The 2017 edition of Science of Military Strategy (战略学), a textbook published by the PLA’s National Defense University that is considered to be relatively authoritative, debuted a section about biology as a domain of military struggle, similarly mentioning the potential for new kinds of biological warfare to include “specific ethnic genetic attacks.”  These are just a few examples of an extensive and evolving literature by Chinese military scholars and scientists who are exploring new directions in military innovation. Following these lines of thinking, the PLA is pursuing military applications for biology and looking into promising intersections with other disciplines, including brain science, supercomputing, and artificial intelligence. Since 2016, the Central Military Commission has funded projects on military brain science, advanced biomimetic systems, biological and biomimetic materials, human performance enhancement, and “new concept” biotechnology.  Meanwhile, China has been leading the world in the number of trials of the CRISPR gene-editing technology in humans. Over a dozen clinical trials are known to have been undertaken, and some of these activities have provoked global controversy. It’s not clear whether Chinese scientist He Jiankui, may have received approval or even funding from the government for editing embryos that became the world’s first genetically modified humans. The news provoked serious concerns and backlash around the world and in China, where new legislation has been introduced to increase oversight over such research. However, there are reasons to be skeptical that China will overcome its history and track record of activities that are at best ethically questionable, or at worst cruel and unusual, in healthcare and medical sciences. But it is striking how many of China’s CRISPR trials are taking place at the PLA General Hospital, including to fight cancer. Indeed, the PLA’s medical institutions have emerged as major centers for research in gene editing and other new frontiers of military medicine and biotechnology. The PLA’s Academy of Military Medical Sciences, or AMMS, which China touts as its “cradle of training for military medical talent,” was recently placed directly under the purview of the Academy of Military Science, which itself has been transformed to concentrate on scientific and technological innovation. This change could indicate a closer integration of medical science with military research.  In 2016, an AMMS doctoral researcher published a dissertation, “Research on the Evaluation of Human Performance Enhancement Technology,” which characterized CRISPR-Cas as one of three primary technologies that might boost troops’ combat effectiveness. The supporting research looked at the effectiveness of the drug Modafinil, which has applications in cognitive enhancement; and at transcranial magnetic stimulation, a type of brain stimulation, while also contending that the “great potential” of CRISPR-Cas as a “military deterrence technology in which China should “grasp the initiative” in development.  The intersection of biotechnology and artificial intelligence promises unique synergies. The vastness of the human genome — among the biggest of big data — all but requires AI and machine learning to point the way for CRISPR-related advances in therapeutics or enhancement.  In 2016 the potential strategic value of genetic information led the Chinese government to launch the National Genebank (国家基因库), which intends to become the world’s largest repository of such data. It aims to “develop and utilize China’s valuable genetic resources, safeguard national security in bioinformatics (生物信息学), and enhance China’s capability to seize the strategic commanding heights” in the domain of biotechnology. The effort is administered by BGI, formerly known as Beijing Genomics Inc., which is Beijing’s de facto national champion in the field. BGI has established an edge in cheap gene sequencing, concentrating on amassing massive amounts of data from a diverse array of sources. The company has a global presence, including laboratories in California and Australia.  U.S. policymakers have been concerned, if not troubled, by the company’s access to the genetic information of Americans. BGI has been pursuing a range of partnerships, including with the University of California and with the Children’s Hospital of Philadelphia on human genome sequencing. BGI’s research and partnerships in Xinjiang also raise questions about its linkage to human rights abuses, including the forced collection of genetic information from Uighurs in Xinjiang. There also appear to be links between BGI’s research and military research activities, particularly with the PLA’s National University of Defense Technology. BGI’s bioinformatics research has used Tianhe supercomputers to process genetic information for biomedical applications, while BGI and NUDT researchers have collaborated on several publications, including the design of tools for the use of CRISPR.  It will be increasingly important to keep tabs on the Chinese military’s interest in biology as an emerging domain of warfare, guided by strategists who talk about potential “genetic weapons” and the possibility of a “bloodless victory.” Although the use of CRISPR to edit genes remains novel and nascent, these tools and techniques are rapidly advancing, and what is within the realm of the possible for military applications may continue to shift as well. In the process, the lack of transparency and uncertainty of ethical considerations in China’s research initiatives raise the risks of technological surprise. https://www.defenseone.com/ideas/2019/08/chinas-military-pursuing-biotech/159167/ …………………. a Chinese Covid Test-Kit Maker You’ve Never Heard of By Josh Nathan-Kazis and Tanner Brown Updated March 3, 2022 5:53 pm ET / Free Covid-19 antigen rapid tests from the federal government made by iHealth, a California-based subsidiary of Andon Health of China. In his State of the Union address on Tuesday, President Biden announced that Americans could soon order a second round of Covid-19 tests from the federal government’s free test program. Most of those tests are the orange-and-white kits made available through a $1.8 billion agreement between the federal government and iHealth Labs, the California-based subsidiary of a Chinese manufacturer, Andon Health . https://www.barrons.com/articles/covid-19-test-maker-ihealth-andon-health-51646318989 ……………................. Kissinger with General Milley, Bill Gates, Obama and Biden